JNJ 17029259

Cat. No. M43550

All AbMole products are for research use only, cannot be used for human consumption.

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

JNJ 17029259 is an orally active and selective VEGF-R2 kinase inhibitor.

Molecular Weight	442.56
Formula	C26H30N6O
CAS Number	314267-57-7
Storage	Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month

Related VEGFR/PDGFR Products
Conbercept Conbercept (KH902) is a monoclonal antibody targeting VEGFRA fused to the IGHG1 Fc fragment. Conbercept is produced by the fusion of the second C-LIKE of FLT1 and the third and fourth C-LIKE of KDR with IGHG1 Fc.
SU5208 SU5208 inhibits vascular endothelial growth factor receptor-2 (VEGFR2).
VEGFR-IN-1 VEGFR-IN-1 is a potent angiogenesis inhibitor with IC50s of 0.02, 0.18, 0.24 7.3, and 7 µM for KDR, Flt-1, c-Kit, EGF-R, and c-Src, respectively.
(Z)-Orantinib (Z)-Orantinib ((Z)-SU6668) is a potent, selective, orally active and ATP competitive inhibitor of Flk‐1/KDR, PDGFRβ, and FGFR1, with IC50s of 2.1, 0.008, and 1.2 µM, respectively.
(Rac)-SAR131675 (Rac)-SAR131675 is the racemate of SAR131675.

Catalog